FORT LAUDERDALE, Fla,, Feb. 23, 2011 (GLOBE NEWSWIRE) -- NovaGold Resources, Inc. (NYSE Amex:NG) and Hemispherx Biopharma, Inc. (NYSE Amex:HEB) are scheduled to present on the opening night of the Third Annual Spring Break for Wall Street Growth & Value Dinner Conference in sunny Fort Lauderdale, Florida on Tuesday, March 1st, 2011.
Slated to take place at one of the most recognized country clubs in the United States, Deer Creek Country Club in Deerfield Beach, Florida, a cocktail reception will begin at 5:00 p.m., followed on by a keynote presentation about the world and local economy. Dinner will be served at 6:00 p.m. and 30 minute corporate presentations by Nova Gold Resources, Inc. (NYSE Amex:NG) and Hemispherx Biopharma, Inc. (NYSE Amex:HEB) will convene at 6:30 p.m.
Hosted by LDV Capital Management (), Founder and President James DePelisi added: "We are extremely happy to have two significant companies such as Nova Gold (NYSE Amex:NG) and Hemispherx (NYSE Amex:HEB) present on the opening night for Spring Break for Wall Street 2011. What both companies have been doing recently in their respective industries is worth studying. The discussion of gold as a hard asset, as well as potential cures and treatment of viral and immune based chronic disorders, hit home with almost everyone; especially, as we head into the second decade of the 21st Century".
Mr. DePelisi also stated: "As Gold is reaching new all time highs, Nova Gold seems to have a very compelling business model that many peers in their industry respect. At the same time, when one studies what Hemispherx has been doing over the years, with its two flagship products: Alferon N Injection® and the experimental immunotherapeutics/antivirals Ampligen®, it seems that their dedication to these products, are unparalleled."
Call 954-572-7988 to RSVP. People interested in attending should pre- register to receive complimentary admission.
For Complimentary Registration Click:
(Check box: Special Guests of LDV )
ABOUT NOVA GOLD RESOURCES, INC: NovaGold Resources, Inc. is a precious metals company engaged in the exploration and development of mineral properties in Alaska, U.S.A. and British Columbia, Canada. The Company is focused on advancing its two core properties, Donlin Creek and Galore Creek, with the objective of becoming a low-cost million-ounce-a-year gold producer, and offers superior leverage to gold with one of the largest reserve/resource bases of any junior or mid-tier gold company. NovaGold trades on the TSX and NYSE-AMEX under the symbol NG. More information is available at, or by firstname.lastname@example.org.
ABOUT HEMISPHERX BIOPHARMA, INC.: Hemispherx Biopharma, Inc. is an advanced specialty pharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of seriously debilitating disorders. Hemispherx's flagship products include Alferon N Injection(R) (FDA approved for a category of sexually transmitted diseases) and the experimental therapeutics Ampligen(R) and Alferon(R) LDO. Ampligen(R) is an experimental RNA nucleic acid being developed for globally important debilitating diseases and disorders of the immune system. For more information please visit www.hemispherx.net.
ABOUT LDV CAPITAL MANAGEMENT: LDV Capital Management is a Registered Investment Advisory firm licensed with the state of Florida specializing in Financial Advisory, Mergers & Acquisitions, Fairness Opinions and Investment Banking. It's President and Founder is James DePelisi. Mr. DePelisi is also the President of the 45 year old Stock and Bond Club of South Florida (). The Stock & Bond Club of South Florida dinner association is one of largest investment advisor associations in Florida. Over 150 companies have presented before its assembly in the past 16 years, including notable companies: Aflac (); Gold Corp (); Cemex (); and Novartis (). General Electric (
DISCLAIMER: LDV Capital Management is a Registered Investment Advisory firm licensed with the State of Florida. The information herein is not a solicitation to invest, but simply public information compiled from Yahoo Finance, a company press release and information from the company's web site. Information is believed to be reliable, but makes no representation to its accuracy or completeness. LDV does not recommend, warrant, or guarantee the success of any action taken in reliance on statements made in this news release or by any company presentations at the Conference. Due-diligence and professional advice should be sought before making any investment decisions. LDV, nor any of its principles or employees do not hold any stock positions in any of the companies mentioned above.
CONTACT: LDV Capital Management: Tel: 954-746-3117 Email: Jim@LdvCapitalManagement.com